Vaccinex, Inc. (VCNX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 11:48AM EDT. Market open.
| Previous Close | 5.75 |
| Open | 5.90 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 5.32 - 5.90 |
| 52 Week Range | 4.43 - 100.80 |
| Volume | |
| Avg. Volume | 12,779 |
| Market Cap | 8.539M |
| Beta (5Y Monthly) | 0.74 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Steven Cohen's Point72 Asset Management Acquires New Stake in Vaccinex Inc
Point72 Asset Management, led by renowned investor Steven Cohen (Trades, Portfolio), has recently initiated a position in Vaccinex Inc (NASDAQ:VCNX), a biotechnology company focused on cancer and neurodegenerative disease treatment. On February 6, 2024, the firm acquired 1,631,648 shares of Vaccinex Inc, marking a new holding in its investment portfolio. The shares were purchased at a price of $0.5863 each, reflecting a significant move by the firm into the biotech sector.
© 2024 Yahoo. All rights reserved.